Publications by authors named "Lillian Tung"
Article Synopsis
- A study examined the relationship between soluble urokinase plasminogen activator receptor (suPAR) and heart health in breast cancer patients undergoing treatment with doxorubicin, a common chemotherapy drug.
- Researchers monitored a group of 37 women over one year, measuring heart function and various cardiac biomarkers, finding that none developed significant heart problems.
- Ultimately, results showed no significant relationship between suPAR levels and heart toxicity markers, suggesting doxorubicin presents a low risk for heart damage in this patient population.
NEW-ONSET CARDIAC AMYLOIDOSIS WHILE IN REMISSION FROM SYSTEMIC AL AMYLOIDOSIS.
Eur J Case Rep Intern Med
February 2023
Unlabelled: In light chain amyloidosis, a reduction in dFLC to below 40 mg/l is a prerequisite for organ recovery as nearly half of the patients who achieve very good partial haematological responses have improvement in the function of the involved organ. We describe a patient who developed new-onset cardiac amyloidosis despite a post-treatment reduction in dFLC to <10 mg/l.
Learning Points: Patients with light chain (AL) amyloidosis may develop new cardiac involvement despite achieving haematological remission.
Background: Focused transthoracic echocardiography (fTTE) has emerged as a critical diagnostic tool during the COVID-19 pandemic, allowing for efficient cardiac imaging while minimizing staff exposure. The utility of fTTE in predicting clinical outcomes in COVID-19 remains under investigation.
Methods: We conducted a retrospective study of 2,266 hospitalized patients at Rush University Medical Center with COVID-19 infection between March and November 2020 who received a fTTE.